1019 related articles for article (PubMed ID: 14529306)
1. Significance and implementation of RBE variations in proton beam therapy.
Paganetti H
Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
[TBL] [Abstract][Full Text] [Related]
2. Relative biological effectiveness (RBE) values for proton beam therapy.
Paganetti H; Niemierko A; Ancukiewicz M; Gerweck LE; Goitein M; Loeffler JS; Suit HD
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):407-21. PubMed ID: 12023146
[TBL] [Abstract][Full Text] [Related]
3. Radiobiological intercomparison of the 160 MeV and 230 MeV proton therapy beams at the Harvard Cyclotron Laboratory and at Massachusetts General Hospital.
Wouters BG; Skarsgard LD; Gerweck LE; Carabe-Fernandez A; Wong M; Durand RE; Nielson D; Bussiere MR; Wagner M; Biggs P; Paganetti H; Suit HD
Radiat Res; 2015 Feb; 183(2):174-87. PubMed ID: 25587741
[TBL] [Abstract][Full Text] [Related]
4. Biophysical modelling of proton radiation effects based on amorphous track models.
Paganetti H; Goitein M
Int J Radiat Biol; 2001 Sep; 77(9):911-28. PubMed ID: 11576451
[TBL] [Abstract][Full Text] [Related]
5. Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles.
Paganetti H
Phys Med Biol; 2002 Mar; 47(5):747-64. PubMed ID: 11931469
[TBL] [Abstract][Full Text] [Related]
6. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning.
Krämer M; Weyrather WK; Scholz M
Technol Cancer Res Treat; 2003 Oct; 2(5):427-36. PubMed ID: 14529307
[TBL] [Abstract][Full Text] [Related]
7. The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer.
Tilly N; Johansson J; Isacsson U; Medin J; Blomquist E; Grusell E; Glimelius B
Phys Med Biol; 2005 Jun; 50(12):2765-77. PubMed ID: 15930601
[TBL] [Abstract][Full Text] [Related]
8. Systematics of relative biological effectiveness measurements for proton radiation along the spread out Bragg peak: experimental validation of the local effect model.
Grün R; Friedrich T; Krämer M; Scholz M
Phys Med Biol; 2017 Feb; 62(3):890-908. PubMed ID: 28072575
[TBL] [Abstract][Full Text] [Related]
9. Empirical model estimation of relative biological effectiveness for proton beam therapy.
Chen Y; Ahmad S
Radiat Prot Dosimetry; 2012 Apr; 149(2):116-23. PubMed ID: 21593038
[TBL] [Abstract][Full Text] [Related]
10. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
[TBL] [Abstract][Full Text] [Related]
11. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
12. Calculation of relative biological effectiveness for proton beams using biological weighting functions.
Paganetti H; Olko P; Kobus H; Becker R; Schmitz T; Waligorski MP; Filges D; Müller-Gärtner HW
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):719-29. PubMed ID: 9112472
[TBL] [Abstract][Full Text] [Related]
13. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.
Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743
[TBL] [Abstract][Full Text] [Related]
14. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.
Paganetti H
Phys Med Biol; 2014 Nov; 59(22):R419-72. PubMed ID: 25361443
[TBL] [Abstract][Full Text] [Related]
15. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay.
Calugaru V; Nauraye C; Noël G; Giocanti N; Favaudon V; Mégnin-Chanet F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1136-43. PubMed ID: 21075549
[TBL] [Abstract][Full Text] [Related]
16. Relative biologic effectiveness determination in mouse intestine for scanning proton beam at Paul Scherrer Institute, Switzerland. Influence of motion.
Gueulette J; Blattmann H; Pedroni E; Coray A; De Coster BM; Mahy P; Wambersie A; Goitein G
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):838-45. PubMed ID: 15936568
[TBL] [Abstract][Full Text] [Related]
17. Physical and biological factors determining the effective proton range.
Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
Med Phys; 2013 Nov; 40(11):111716. PubMed ID: 24320424
[TBL] [Abstract][Full Text] [Related]
18. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
[TBL] [Abstract][Full Text] [Related]
19. A mechanism-based approach to predict the relative biological effectiveness of protons and carbon ions in radiation therapy.
Frese MC; Yu VK; Stewart RD; Carlson DJ
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):442-50. PubMed ID: 22099045
[TBL] [Abstract][Full Text] [Related]
20. Relative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo.
Sørensen BS; Bassler N; Nielsen S; Horsman MR; Grzanka L; Spejlborg H; Swakoń J; Olko P; Overgaard J
Acta Oncol; 2017 Nov; 56(11):1387-1391. PubMed ID: 28830292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
